Viewing Study NCT04607005


Ignite Creation Date: 2025-12-25 @ 3:29 AM
Ignite Modification Date: 2026-04-18 @ 6:33 AM
Study NCT ID: NCT04607005
Status: COMPLETED
Last Update Posted: 2024-11-25
First Post: 2020-10-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)/ Eosinophilic Chronic Rhinosinusitis (ECRS)
Sponsor: GlaxoSmithKline
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 209692
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None OTHER View